Using a HFD model of obesity and early‐stage NAFLD, the current study failed to detect an effect of hepatocellular IL‐1R1 on bodyweight or dyslipidaemia. The gene discussed is IL1R1; the disease is metabolic dysfunction-associated steatotic liver disease.